Clinical Trial Update: Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice

View source ↗

Summary

Post-marketing surveillance study assessing safety and efficacy of Viviant in usual practice for osteoporosis; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Viviant

Snippet

Sponsor: Pfizer | Conditions: Osteoporosis | Status: COMPLETED | Results posted: 2018-12-24